Clinical Trial: High-Dose Rosuvastatin Preloading for Enhanced Outcomes in STEMI Patients Undergoing Primary PCI

U.S., April 12 -- ClinicalTrials.gov registry received information related to the study (NCT06924684) titled 'High-Dose Rosuvastatin Preloading for Enhanced Outcomes in STEMI Patients Undergoing Primary PCI' on Dec. 30, 2024.

Brief Summary: To compare the efficacy of high dose rosuvastatin preloading vs placebo before primary PCI in terms of MACE at 30 days

Study Start Date: Dec. 02, 2024

Study Type: INTERVENTIONAL

Condition: ST Elevation (STEMI) Myocardial Infarction

Intervention: DRUG: Statin monotherapy (rosuvastatin or atorvastatin)

Tab Rosuvastatin 40mg (weight) at presentation. Tab Rosuvastatin 20mg at night for 30 days.

DRUG: Placebo

Placebo caspule

Recruitment Status: ACTIVE_NOT_RECRUITING

Sponsor: Sheikh Zayed Federal P...